PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-May-2025 APONTIS PHARMA publishes results for the first quarter of 2025 and confirms forecast for 2025 APONTIS PHARMA AG
15-May-2025 DOUGLAS Group on track to reach guidance for FY 2024/25 - significantly improved net income Douglas AG
15-May-2025 Cantourage achieves another record revenue: EUR 11.1 million in April 2025 Cantourage Group SE
15-May-2025 Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics Holding SA
15-May-2025 SCHOTT Pharma delivers strong second quarter of fiscal year 2025 SCHOTT Pharma AG & Co. KGaA
15-May-2025 SKAN provides in-depth insight into its growth strategy and pre-approved services on its first Capital Market Day SKAN AG
14-May-2025 Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 Heidelberg Pharma AG
14-May-2025 GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) GSK
14-May-2025 Asklepios Group: Stable business performance in Q1 2025 Asklepios Kliniken
14-May-2025 Nyxoah Reports First Quarter Financial and Operating Results Nyxoah SA.
13-May-2025 Medios starts 2025 financial year successfully with significant increase in earnings Medios AG
13-May-2025 Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast Eckert & Ziegler SE
12-May-2025 Medios repositions itself for the next phase of its corporate development Medios AG
12-May-2025 Changes to the Medios AG Executive Board; Matthias Gärtner will leave the company Medios AG
12-May-2025 Biotest confirms Guidance for 2025 Biotest AG
12-May-2025 Gerresheimer Successfully Completes Investment in State-of-the-Art Glass Production Facility in Lohr Gerresheimer AG
12-May-2025 Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement Secarna Pharmaceuticals GmbH & Co. KG
12-May-2025 Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate Thermosome
12-May-2025 Kroyf Labcorp Expands Its Presence as Leading Pharma Franchise Company in Panchkula Kroyf Labcorp
12-May-2025 AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025. AEVIS VICTORIA SA